Cough syrup contaminated with DEG has caused ARI and the death of many children in The Gambia.

Published Date: 06 Mar 2023

USA: The syrup drug Diethylene glycol (DEG), a drug commonly used to prevent infections, is the cause of kidney disease...

Read Full News

Latest News

MIL62 Shows Increased Remission and Reduced Relapse Versus Cyclosporine A in MN

MIL62 Shows Increased Remission and Reduced Relapse Versus Cyclosporine A in MN

Understanding Atacicept & 36-Week ORIGIN 3 Data from Kidney Week 2025, With Jonathan Barratt, MBChB, PhD Jonathan Barratt, MBChB, PhD, FRCP

Jonathan Barratt, MBChB, PhD, discusses 36-week atacicept data from ASN Kidney Week 2025.

Telitacicept Achieves Primary Endpoint in IgA Nephropathy Phase 3 Study

Telitacicept Achieves Primary Endpoint in IgA Nephropathy Phase 3 Study

Pre-Conception Hypertension Linked to Adverse Pregnancy Outcomes in IgA Nephropathy

Pre-Conception Hypertension Linked to Adverse Pregnancy Outcomes in IgA Nephropathy

Gross Hematuria After COVID Vaccination Linked to Short-Term Kidney Function Decline in IgAN Abigail Brooks, MA

Increases in short-term kidney function decline were observed following post-COVID-19 vaccination gross hematuria in individuals with IgA nephropathy.

Navigating Treatment Decisions In IgAN, With Jai Radhakrishnan, MD Jai Radhakrishnan, MD

Radhakrishnan emphasizes the importance of individualized IgAN care and how to best use currently available and emerging treatments.

Todays Updates

Multi-Arm Phase 2 Trial Fails to Show Efficacy for Cognitive Programs in Treating Long COVID Marco Meglio

A recent trial reveals that online cognitive training and other interventions are ineffective for treating long COVID cognitive symptoms, highlighting treatment challenges.

Todays Updates

Multi-Arm Phase 2 Trial Fails to Show Efficacy for Cognitive Programs in Treating Long COVID Marco Meglio

A recent trial reveals that online cognitive training and other interventions are ineffective for treating long COVID cognitive symptoms, highlighting treatment challenges.

Latest News

MIL62 Shows Increased Remission and Reduced Relapse Versus Cyclosporine A in MN

Jonathan Barratt, MBChB, PhD, discusses 36-week atacicept data from ASN Kidney Week 2025.

Telitacicept Achieves Primary Endpoint in IgA Nephropathy Phase 3 Study

Pre-Conception Hypertension Linked to Adverse Pregnancy Outcomes in IgA Nephropathy

Increases in short-term kidney function decline were observed following post-COVID-19 vaccination gross hematuria in individuals with IgA nephropathy.

Radhakrishnan emphasizes the importance of individualized IgAN care and how to best use currently available and emerging treatments.

News All Time

ASN Kidney Week 2025 Preview: 5 Phase 3 Trials to Know Patrick Campbell

Kidney Week 2025 showcases groundbreaking clinical trials and FDA approvals, marking a transformative era in nephrology and kidney disease treatment.

5 Nephrology Headlines You Missed in October 2025 Alex Hillenbrand

October brings FDA approvals, new KDIGO guidance, and diagnostic breakthroughs

FDA Grants Orphan Drug Designation to ABBV-CLS-628 for ADPKD Alex Hillenbrand

ABBV-CLS-628, an anti–PAPP-A monoclonal antibody, earns Orphan Drug Designation, advancing through phase 2 testing for ADPKD.

FDA Approves Kygevvi, First Treatment for Thymidine Kinase 2 Deficiency Alex Hillenbrand

The FDA has approved Kygevvi (doxycitine and doxribtimine), the first therapy to improve functional outcomes and survival in thymidine kinase 2 deficiency.

Kidney Week 2025: ORIGIN 3 Sets the Stage for Atacicept in IgA Nephropathy Patrick Campbell

Phase 3 trial results reveal atacicept significantly reduces proteinuria in IgA nephropathy, paving the way for potential FDA approval in 2026.

FINE-ONE: Finerenone Proves Benefit in Type 1 Diabetes and CKD Patrick Campbell

Finerenone significantly reduces UACR in type 1 diabetes patients with chronic kidney disease, offering new hope for treatment.

Anxiety, Depression Linked to Poor Sleep Quality in ESRD Patients on HD Alex Hillenbrand

Findings showed anxiety, depression, and sleep disorders were highly prevalent among ESRD patients undergoing maintenance hemodialysis

DUPLEX: Sparsentan Outperforms Irbesartan in Reaching Key Proteinuria Threshold in FSGS Victoria Johnson

New findings reveal sparsentan significantly reduces proteinuria in FSGS patients, offering hope for improved kidney health and lower failure risk.

BESTOW: Tegoprubart Showcases Safer Prevention of Kidney Transplant Rejection Over Tacrolimus Victoria Johnson

Tegoprubart shows promise as a safer alternative to tacrolimus in kidney transplants, enhancing graft function with fewer side effects.

PISCES: Fish Oil Slashes Cardiovascular Event Risk of Maintenance Dialysis Victoria Johnson

New data on daily fish oil supplementation prompts discussions on clinical recommendations.

Almost All Adults With Hypertensive CKD Would Benefit From Lower Blood Pressure Target

Almost All Adults With Hypertensive CKD Would Benefit From Lower Blood Pressure Target

Younger Age at Glomerular Disease Diagnosis Linked to Greater Lifetime Risk Despite Similar Progression Rates

Younger Age at Glomerular Disease Diagnosis Linked to Greater Lifetime Risk Despite Similar Progression Rates

Uptrend in Acute Kidney Injury Mortality in Higher Socioeconomic Countries Projected to Continue

Uptrend in Acute Kidney Injury Mortality in Higher Socioeconomic Countries Projected to Continue

Sibeprenlimab Safely Reduces Gd-IgA1, Other IgAN Markers, in New Analysis

Sibeprenlimab Safely Reduces Gd-IgA1, Other IgAN Markers, in New Analysis

FDA Clears IND Application for EGEN-2784, a Genetically Engineered Pig Kidney, for ESKD

FDA Clears IND Application for EGEN-2784, a Genetically Engineered Pig Kidney, for ESKD

Hypertensive Kidney Disease Death Rate Up 48% in Past 25 Years

Hypertensive Kidney Disease Death Rate Up 48% in Past 25 Years

Recommended News For You

New guidelines for radiation therapy for HPV-associated head and neck cancer

AZD0486 Shows Good Efficacy in Relapsed/Refractory Follicular Lymphoma

Breast cancer screening in women's 40s can save lives, study says

New Clues to Origin of T-Cell Lymphoma After CAR-T Therapy

Getting Lung Cancer Screening Staff Involved Improved Tobacco Cessation

Big PFS Increase in Advanced Neuroendocrine Tumors With Combination Therapy

ALK-positive lung cancer trial results show unprecedented progression-free survival.

Recommended Articles For You

Beyond the Blinders: A Review of Targeted Therapeutic Strategies for Triple-Negative Breast Cancer in 2025 

Survival Rate Dynamics in Hematologic and Solid Malignancies 

Is p53 the Missing Puzzle Piece? Exploring Its Polymorphisms in Cervical Cancer Risk 

Exploring the Mysteries of MGUS: Uncovering the Causes and Treatments 

Whats more on Hidoc Dr.

Medical Updates
KOL Videos
Surveys
Events

Daily news to keep you up to date

Gain valuable insights with our in-depth KOL Video discussions

Participate and win cash vouchers

Get updates on the latest events happening around the world
Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Cancer cells with thick glycocalyx barrier evade immune system better: study

2.

Report suggests a big improvement in lung cancer survival

3.

The prognosis of the Slovakian PM; Kate Middleton's treatment; and drug test cheating.

4.

For patients with prostate cancer, long-term follow-up helps identify treatment side effects.

5.

More pain, more gain? New biopsy technique found to improve prostate cancer detection

1.

Interplay of Brown Hair, Follicular Biology, and Hair Growth Inhibitors in Melanoma Pathogenesis

2.

Cancer Staging: Updates, Clinical Insights, and Educational Resources for Medical Professionals

3.

The Millionaire's Battle: Does Mark Cuban Have Cancer?

4.

The Ultimate Guide to Understanding Abiraterone and its Uses in Cancer Treatment 

5.

KEYNOTE-826: Optimizing Outcomes in Persistent, Recurrent, or Metastatic Cervical Cancer

1.

International Lung Cancer Congress®

2.

Genito-Urinary Oncology Summit 2026

3.

Future NRG Oncology Meeting

4.

ISMB 2026 (Intelligent Systems for Molecular Biology)

5.

Annual International Congress on the Future of Breast Cancer East

1.

Molecular Contrast: EGFR Axon 19 vs. Exon 21 Mutations - Part VI

2.

Managing ALK+ NSCLC while Ensuring Long-Term Safety of the Patients

3.

An In-Depth Look At The Signs And Symptoms Of Lymphoma

4.

First-Line Maintenance Therapy for Metastatic Urothelial Carcinoma: Bridging Clinical Practice and Trials

5.

Understanding the Evolution in Lung Cancer- An Initiative from Manipal Hospitals: Further Discussion

Fastest Growing Medical Platform for Doctors

Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801

Phone :
+1-415-463-3094

Email :
anishagadia@hidoc.co

Quick Links

Drug DatabaseDrug InteractionDiseases Database
KOL VideosKnowledge HubQuizzes
Medical UpdatesEventsAbout Us

© Copyright 2025 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
Home
Profile
Login
bot